Lilly Oncology On Canvas Celebrates 10 Years of Cancer Journeys - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lilly Oncology On Canvas Celebrates 10 Years of Cancer Journeys


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 6

Participants at the American Society of Clinical Oncology's (ASCO) Annual Meeting in Chicago were invited to mark National Cancer Survivor's Day on June 1 through artistic expression and help create a mural of a caregiver's artistic interpretation of her sister's journey with lung cancer.

The Hope Murals Project marks the 10th anniversary of the Lilly Oncology On Canvas Art Competition, which invites residents of the US and Puerto Rico who have been affected by cancer to express, through art and narrative, the meaning of their cancer journeys. The Hope Murals Project brings 10 murals based on art from past competitions to 10 cities across the US and Puerto Rico.

Marking the official launch of The Hope Murals Project, oncology professionals came together at ASCO to create the mural using a "paint-by-number" process. The subject of the mural painted at ASCO is "Creating a New Universe," a 2010 Oncology On Canvas competition entry by Chicago resident Gloria Cichy.

Each of the 10 works to be transformed into Hope Murals is chosen through public vote on the Lilly Oncology On Canvas Facebook page. The first mural was completed in Anaheim, CA, by attendees of the Oncology Nursing Society's 39th Annual Congress, and was permanently installed at the Anaheim Central Library.

Source: Lilly Oncology On Canvas Art Competition

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here